Patrick Connerty

6PUBLICATIONS
33CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2026
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia.

|May 12, 2026
Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

|Mar 31, 2026
CRISPR-Cas9 Genome-Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies.

Steven He, Patrick Connerty, Antoine de Weck

|Feb 21, 2025
Immune-deficient MISTRG mice support expansion of leukaemia-initiating cells in xenograft models of paediatric acute myeloid leukaemia.

Patrick Connerty, Jinhan Xie, Fatima El-Najjar

|Jun 02, 2023
The tip of the iceberg-The roles of long noncoding RNAs in acute myeloid leukemia.

Patrick Connerty, Richard B Lock

|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.

Ernest Moles, Christopher B Howard, Pie Huda

Pageof 1

Frequent Collaborators

1 joint publications

Ernest Moles

1 joint publications

Christopher B Howard

1 joint publications

Pie Huda

1 joint publications

Mawar Karsa